In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with esca…

published 2018-08-22 8y ago modified 2026-06-17 4mo ago also EUVD-2018-6671

cvss: 7.8; version 3.1, NVD
cisa kev: Not listed; not in CISA's catalog
epss: 0.4%; EPSS 0.4% chance of exploitation in 30 days, percentile 33%
public exploits: 0; none known

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.

Is CVE-2018-14787 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

Exploit prediction

0.39% chance of exploitation in the next 30 days, higher than 33% of all scored CVEs (FIRST EPSS, 2026-11-09).

CVSS scores

assigned by	version	score	vector
NVD	3.1	7.8	CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
NVD	2.0	4.6	AV:L/AC:L/Au:N/C:P/I:P/A:P

Affected products

Philips IntelliSpace Cardiovascular (ISCV) products

Classification

Weakness

CWE-269 Improper Privilege Management

References

usa.philips.com /healthcare/about/customer-support/product-security
vendor-advisory
ics-cert.us-cert.gov /advisories/ICSMA-18-226-01
third-party-advisory, us-government-resource

Sources

CVE List CVE-2018-14787
NVD CVE-2018-14787

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.